Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation

Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.bmcl.2007.08.078

Title:	Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation
Authors:	Thimmegowda, N.R. Nanjunda Swamy, S. Ananda Kumar, C.S. Sunil Kumar, Y.C. Chandrappa, S. Yip, G.W. Rangappa, K.S.
Keywords:	Cell proliferation MDA-MB-231 Trisubstituted benzimidazole
Issue Date:	1-Jan-2008
Citation:	Thimmegowda, N.R., Nanjunda Swamy, S., Ananda Kumar, C.S., Sunil Kumar, Y.C., Chandrappa, S., Yip, G.W., Rangappa, K.S. (2008-01-01). Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Bioorganic and Medicinal Chemistry Letters 18 (1) : 432-435. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bmcl.2007.08.078
Abstract:	A novel series of trisubstituted benzimidazole and its precursors (3-7) were synthesised and characterized by using 1H NMR, LC/MS, FTIR and elemental analysis techniques. The title compounds were evaluated for inhibition against MDA-MB-231 breast cancer cell proliferation. The results revealed that the compound N-(4-cyano-3-(trifluoromethyl) phenyl)-4-fluoro-3-nitrobenzamide (3) was the potent inhibitor. © 2007 Elsevier Ltd. All rights reserved.
Source Title:	Bioorganic and Medicinal Chemistry Letters
URI:	http://scholarbank.nus.edu.sg/handle/10635/120673
ISSN:	0960894X
DOI:	10.1016/j.bmcl.2007.08.078
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check